approval
saveDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalMar 10, 2026 · 206d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalMay 6, 2022 · 1610d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalAug 12, 2019 · 2608d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalMar 29, 2016 · 3839d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalDec 28, 2015 · 3931d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalOct 9, 2015 · 4011d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalApr 16, 2015 · 4187d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalJan 22, 2015 · 4271d ago
comments(0)
5-min edit window · permanent after that